Phenylpiracetam
| Phenylpiracetam | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 218.25 g/mol [1] |
| Predicted LogP | 0.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H14N2O2 [1] |
| IUPAC name | 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide [1] |
| SMILES | C1C(CN(C1=O)CC(=O)N)C2=CC=CC=C2 [1] |
| InChI | InChI=1S/C12H14N2O2/c13-11(15)8-14-7-10(6-12(14)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,13,15) [1] |
| InChIKey | LYONXVJRBWWGQO-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 3 – 5 hours |
Phenylpiracetam (also known as Fonturacetam, 4-Phenylpiracetam, Carphedone, Carphedon, Karfedon, 2-Oxo-4-phenyl-1-pyrrolidineacetamide, 1-Pyrrolidineacetamide, 2-oxo-4-phenyl-, Brn 5030440, Phenotropyl or 2-(2-oxo-4-phenyl-pyrrolidin-1-yl)acetamide) is a
Chemistry
Stereochemistry []
Phenylpiracetam is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Druglikeness
Lipinski's rule of five
Phenylpiracetam matches Lipinski's rule of five.Legal status []
- Australia: Phenylpiracetam is a S4 substance.
- United States: Phenylpiracetam is a Unapproved drug; use in dietary supplements, food, or medicine is unlawful..
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 132441, Phenylpiracetam. Accessed June 12, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/132441